U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794840) titled 'JomCare Study - Microrandomized Trial' on Jan. 23.
Brief Summary: Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.
Study Start Date: June 01, 2025
Study...